| | |
(1) Application for a licence, in respect of — |
| | |
(a) the initial screening# |
| | |
(b) the evaluation* for — |
| | |
(i) an innovator product containing new chemical or biological entity, new combination, new dosage form or new route of administration — single-strength product or first product in a series of products of different strengths |
| | |
(ii) an innovator product containing new chemical or biological entity, new combination, new dosage form or new route of administration — subsequent product in a series of products of different strengths |
| | |
(iii) a generic drug product — single-strength product or first product in a series of products of different strengths |
| | |
(iv) a generic drug product — subsequent product in a series of products of different strengths |
| | |
| | |
| | |
| | |
(3) Application to amend a licence — |
| | |
(a) to make changes to product specifications relating to indications, dosage recommendations or patient groups, in respect of — |
| | |
(i) the initial screening# |
| | |
(ii) the evaluation* for a single-strength product or the first product in a series of products of different strengths |
| | |
(iii) the evaluation* for a subsequent product in a series of products of different strengths |
| | |
(b) to make any other changes to product specifications |
| | |
| | |
| | |
(1) Application for a licence for — |
| | |
(a) importation authorised by product licence holder |
| | |
(b) importation not authorised by product licence holder — per consignment imported |
| | |
| | |
(a) importation authorised by product licence holder for — |
| | |
| | |
(ii) each subsequent year |
| | |
(b) importation not authorised by product licence holder — per consignment imported |
| | |
(3) Application to amend a licence — |
| | |
| | |
(b) without site inspection |
| | |
| | |
3. WHOLESALE DEALER’S LICENCE |
| | |
(1) Application for a licence |
| | |
| | |
| | |
| | |
(3) Application to amend a licence — |
| | |
| | |
(b) without site inspection |
| | |
| | |
4. MANUFACTURER’S LICENCE |
| | |
(1) Application for a licence for — |
| | |
(a) manufacture of external preparations |
| | |
(b) manufacture of oral preparations |
| | |
(c) manufacture of contact lens solutions |
| | |
(d) manufacture of external and oral preparations |
| | |
(e) manufacture of sterile preparations or other types of dosage forms, or dosage form combinations other than the above |
| | |
| | |
| | |
| | |
| | |
(b) each subsequent year for — |
| | |
(i) a manufacturer of external preparations |
| | |
(ii) a manufacturer of oral preparations |
| | |
(iii) a manufacturer of contact lens solutions |
| | |
(iv) a manufacturer of external and oral preparations |
| | |
(v) a manufacturer of sterile preparations or other types of dosage forms, or dosage form combinations other than the above |
| | |
| | |
(vii) a secondary assembler |
| | |
(3) Application to amend a licence — |
| | |
(a) with site inspection (for manufacturer) |
| | |
(b) with site inspection (for assembler) |
| | |
(c) without site inspection |
| | |
| | |
5. CERTIFICATES AND DOCUMENTS (NON-MANDATORY) |
| | |
(1) a Certificate to Export a Medicinal Product |
| | |
(2) a Confirmation of Authorisation to Import Psychotropic Substances |
| | |
(3) a Confirmation of Authorisation to Import Restricted Substances |
| | |
(4) a Statement of Licensing Status of a Medicinal Product |
| | |